Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,258 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

NCT02059499

Conditions
Anal Intraepithelial Neoplasia, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • UCLA CARE Center Los Angeles, California, United States
  • UCSF-Mount Zion San Francisco, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

NCT04193189

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center San Diego, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
View all 41 locations
View Trial Details
Completed

A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

NCT04214028

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Kariya Toyota General Hospital /ID# 239046 Kariya-shi, Aichi-ken, Japan
  • Meijo Hospital /ID# 250955 Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital /ID# 226746 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 238745 Nagoya, Aichi-ken, Japan
View all 54 locations
View Trial Details
Completed

Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities

NCT05549180

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • H. Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
  • CHUAC A Coruña, Spain
  • Hospital de Bellvitge Barcelona, Spain
  • Hospital Universitario Reina Sofía Córdoba, Spain
View all 14 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load

NCT05898841

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +16 more
Locations
  • Hospital Universitario Gregorio Marañon Madrid, Spain
  • Hospital universitario Infanta Leonor Madrid, Spain
  • Hospital Universitario Infanta Sofía Madrid, Spain
  • Hospital Universitario La Paz Madrid, Spain
View Trial Details
Completed

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV

NCT04556981

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Wits RHI Johannesburg, Gauteng, South Africa
  • Ekhaya VAC Cape Town, Khayelitsha, South Africa
  • CAPRISA Durban, KwaZulu-Natal, South Africa
  • The Aurum Institute Klerksdorp, North West, South Africa
View Trial Details

Related conditions